Home About Products & Services News Research Investors Contact
Company Profile
Mission Statement
Our Commitment
Neuronetics Team
Board of Directors
Careers at
Neuronetics


Leslie Bottorff - General Partner, ONSET Ventures

Michael D. Dale - President, CEO, ATS Medical

Wilfred Jaeger, M.D. - Partner, Three Arch Partners

Liam Ratcliffe, M.D., Ph.D. - Venture Partner, New Leaf Venture Partners

P. Sherrill Neff - Partner, Quaker BioVentures

Dan Sachs, M.D. - Entrepreneur, Board Representative for Investor Growth Capital

Bruce J. Shook - President, CEO Neuronetics, Inc.

Kevin J. Bitterman Ph.D. - Principal, Polaris Venture Partners

Brian Farley - Former President and CEO of VNUS Medical Technologies

Find a NeuroStar TMS Therapy Provider Near You

If you or a loved one is suffering from major depression, you can find a NeuroStar TMS Therapy provider in your area.

Provide NeuroStar TMS Therapy in Your Practice

Provide your patients the new way back with NeuroStar TMS Therapy®. Contact us to find out how you can begin providing therapy.
Copyright © 2010 Neuronetics. All Rights Reserved Site Map | Privacy Policy | Terms & Conditions | Glossary

This link provides you with access to recent published information and news about NeuroStar TMS Therapy and new options for the treatment of depression. Neuronetics does not provide any assurances of the accuracy of this information and may not agree with the opinions of the authors.

NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. To return to the Neuronetics website for full safety and prescribing information click here.

Click here to continue.